BBI
BSX icon

Baxter Bros Inc’s Boston Scientific BSX Stock Holding History

Baxter Bros Inc’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,075
Closed -$256K – 175
2026
Q1 		$256K Sell
4,075
-35
-0.9% -$2.8K 0.03% 151
2025
Q4 		$392K Hold
4,110
– – 0.05% 123
2025
Q3 		$401K Hold
4,110
– – 0.05% 125
2025
Q2 		$441K Buy
4,110
+40
+1% +$4.05K 0.05% 112
2025
Q1 		$411K Hold
4,070
– – 0.05% 116
2024
Q4 		$364K Hold
4,070
– – 0.05% 120
2024
Q3 		$341K Hold
4,070
– – 0.04% 128
2024
Q2 		$313K Buy
4,070
+25
+0.6% +$1.83K 0.04% 128
2024
Q1 		$277K Buy
4,045
+33
+0.8% +$2.12K 0.04% 131
2023
Q4 		$232K Buy
+4,012
New +$214K 0.03% 143

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baxter Bros Inc's BSX Position: Q2 2026 in Review

Baxter Bros Inc sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,075 shares — an estimated $256K sold.

Baxter Bros Inc first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $441K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Baxter Bros Inc reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Baxter Bros Inc sold 4,075 Boston Scientific shares in Q2 2026, an estimated $256K.
  • Baxter Bros Inc first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
  • Baxter Bros Inc's Boston Scientific position peaked at $441K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.